Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies
Recombinant therapeutic proteins, of which monoclonal antibodies (mAbs) represent the largest market, are used to treat diseases including cancer, blood and immune disorders. The cost and complexity of large-scale production and purification of mAbs translates to high cost of therapy. We hypothesise...
Những tác giả chính: | Antepowicz, A, Tan, A, Pringle, A, Hyde, S, Gill, D |
---|---|
Định dạng: | Conference item |
Được phát hành: |
Mary Ann Liebert Inc
2016
|
Những quyển sách tương tự
-
Development of lung and muscle factories to deliver therapeutic monoclonal antibodies
Bằng: Antepowicz, A
Được phát hành: (2018) -
431. Lung antibody factory for passive immunisation against influenza
Bằng: Tan, T, et al.
Được phát hành: (2016) -
Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
Bằng: Du, Y, et al.
Được phát hành: (2020) -
Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
Bằng: Antepowicz, A, et al.
Được phát hành: (2018) -
The lung as a factory to produce secreted intrapulmonary and circulatory proteins
Bằng: Paul-Smith, M, et al.
Được phát hành: (2017)